Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Jonathan Burton to receive RPS Charter Award for promoting the interests of pharmacy

Jonathan Burton will receive the 2022 RPS Charter Award for his outstanding work for the Society and the wider profession in promoting the interests of pharmacy.

The award will be presented by the President at a future meeting of Fellows and Members to take place at the Society’s Edinburgh office on 22nd March 2023.


Jonathan’s main role is as a practising, patient-facing pharmacist within the community in NHS Forth Valley where he uses his advanced practice skills and independent prescribing qualification to assess and treat acute ENT, dermatology, and respiratory conditions.

He was one of the first community pharmacist prescribers in Scotland and has always been at the forefront of innovation and service development.

Jonathan has demonstrated outstanding commitment and passion for the pharmacy profession throughout his career. He has excelled as a pharmacist in the Right Medicine Pharmacy group, on local and national committees, in advocacy for the pharmacy profession and as a local and national leader who is highly regarded as an exceptional role model for the profession.

His commitment to helping support and enhance the Royal Pharmaceutical Society (RPS) as a Scottish Pharmacy Board Member has been particularly significant: serving on the Board from 2012 – 2021 including time as Vice Chair and, from 2019 – 2021, Chair of the Board and Assembly Member.

Jonathan is an ambassador for the pharmacy profession, a true champion for community pharmacy and an exceptional leader. His practical, compassionate, and realistic nature and his ability to make everyone in the room feel valued and equal regardless of their skills, knowledge, or experience.

His outstanding contribution to pharmacy, patient care and his local community was recognised in 2018 when he was made a Member of the Order of the British Empire (MBE).

RPS President Professor Claire Anderson said: “Jonathan has had a significant impact on the practice of pharmacy. He has run an innovative pharmacy in Stirling for many years. He was one of the first community pharmacy prescribers. It was a pleasure to work with him when we were both board chairs and I am delighted to be able to present him with this prestigious award.”

Upon hearing of the Award, Jonathan Burton said: "I am absolutely delighted to receive the RPS Charter Award. For me, being a pharmacist and helping the public is a privilege. I've been very fortunate to have amazing support from family and colleagues throughout my career and I feel this recognition of my contribution belongs as much to them as it does to me.

“I'd like to pay particular tribute to the dedication and professionalism of all the pharmacy teams across Scotland, and those working in the various organisations that support them, who help deliver the Pharmacy First service to patients every day. It was a great experience to be involved in the early development of this service and it's a fantastic example of a shared vision for pharmacy becoming a reality. My involvement with RPS has always helped widen my professional perspective, supported my practice and I will always consider my membership, supporting other members and the wider profession to be a lifelong commitment."

Any Member or Fellow of the Society is eligible for nomination (with the exception of current Board and Assembly members who are ineligible whilst holding office). Nominations for the Charter Award can be made through the national Pharmacy Boards or Assembly members and are assessed by a panel consisting of the President, Treasurer and the three national Board Chairs.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less